Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5088962018 | Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 5088963011 | Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens only vaccine product | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| 5088964017 | Haemophilus influenzae type b and meningitis C and Y vaccine | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) | Is a | Vaccine product containing Neisseria meningitidis antigen (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) | Plays role | Active immunity stimulant role | true | Inferred relationship | Existential restriction modifier | ||
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) | Count of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) | Is a | Vaccine product containing Haemophilus influenzae type b antigen (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) | Has active ingredient | Antigen of Haemophilus influenzae type b | true | Inferred relationship | Existential restriction modifier | 1 | |
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) | Has active ingredient | Antigen of Neisseria meningitidis serogroup Y | true | Inferred relationship | Existential restriction modifier | 2 | |
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) | Has active ingredient | Antigen of Neisseria meningitidis serogroup C | true | Inferred relationship | Existential restriction modifier | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Administration of vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens | Direct substance | True | Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets
FHIR